ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE000MLMNYS0
Stock Name / FundiShares S&P 500 Equal Weight UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerEWSP.AS(USD) CXE
ETF TickerEWSP.LS(GBP) CXE
ETF TickerEWSP.MI(EUR) CXE
ETF TickerEWSP(EUR) ETF Plus

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 Equal Weight UCITS ETF USD (Acc) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2026-02-09 (Monday)12,960REGN holding increased by 96USD 10,112,429REGN holding increased by 7628USD 10,112,42996USD 7,628 USD 780.28 USD 785.51
2026-02-06 (Friday)12,864REGN holding increased by 352USD 10,104,801REGN holding increased by 657991USD 10,104,801352USD 657,991 USD 785.51 USD 755.02
2026-02-02 (Monday)12,512REGN holding increased by 40USD 9,446,810REGN holding increased by 199446USD 9,446,81040USD 199,446 USD 755.02 USD 741.45
2026-01-30 (Friday)12,472REGN holding increased by 56USD 9,247,364REGN holding decreased by -57683USD 9,247,36456USD -57,683 USD 741.45 USD 749.44
2026-01-29 (Thursday)12,416REGN holding increased by 32USD 9,305,047REGN holding increased by 3053USD 9,305,04732USD 3,053 USD 749.44 USD 751.13
2026-01-28 (Wednesday)12,384REGN holding increased by 8USD 9,301,994REGN holding decreased by -242996USD 9,301,9948USD -242,996 USD 751.13 USD 771.25
2026-01-27 (Tuesday)12,376USD 9,544,990REGN holding increased by 106434USD 9,544,9900USD 106,434 USD 771.25 USD 762.65
2026-01-26 (Monday)12,376USD 9,438,556REGN holding increased by 112621USD 9,438,5560USD 112,621 USD 762.65 USD 753.55
2026-01-23 (Friday)12,376REGN holding increased by 120USD 9,325,935REGN holding increased by 66404USD 9,325,935120USD 66,404 USD 753.55 USD 755.51
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE000MLMNYS0

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-02-09BUY96 780.280* -
2026-02-06BUY352 785.510* -
2026-02-02BUY40763.560731.510 734.715USD 29,389 -
2026-01-30BUY56774.365735.610 739.485USD 41,411 -
2026-01-29BUY32755.730742.885 744.170USD 23,813 -
2026-01-28BUY8766.985747.690 749.620USD 5,997 -
2026-01-23BUY120762.000747.300 748.770USD 89,852 -
2026-01-22BUY176764.890747.370 749.122USD 131,845 -
2026-01-21BUY8749.550735.000 736.455USD 5,892 -
2026-01-20BUY216737.870718.380 720.329USD 155,591 -
2026-01-16SELL-88749.090726.950 729.164USD -64,166 -
2026-01-15BUY192756.500738.620 740.408USD 142,158 -
2026-01-13BUY40765.990743.940 746.145USD 29,846 -
2026-01-09SELL-104821.110790.930 793.948USD -82,571 -
2026-01-08BUY224816.990800.680 802.311USD 179,718 -
2026-01-06BUY8785.405763.195 765.416USD 6,123 -
2026-01-05BUY24771.990753.199 755.078USD 18,122 -
2025-12-30BUY8777.720770.305 771.046USD 6,168 -
2025-12-22BUY80783.600765.090 766.941USD 61,355 -
2025-12-19SELL-3,371773.850748.180 750.747USD -2,530,768 -
2025-12-18SELL-30752.840739.230 740.591USD -22,218 -
2025-12-17BUY200751.990743.330 744.196USD 148,839 -
2025-12-15BUY140756.660746.375 747.403USD 104,636 -
2025-12-12BUY80746.050734.380 735.547USD 58,844 -
2025-12-11BUY20753.565726.455 729.166USD 14,583 -
2025-12-05BUY20736.150717.265 719.153USD 14,383 -
2025-12-04BUY10735.000721.220 722.598USD 7,226 -
2025-12-03BUY40744.225720.140 722.549USD 28,902 -
2025-12-01BUY50779.840748.210 751.373USD 37,569 -
2025-11-28BUY110788.980779.500 780.448USD 85,849 -
2025-11-24BUY180773.130756.640 758.289USD 136,492 -
2025-11-21BUY20764.090735.740 738.575USD 14,771 -
2025-11-11SELL-10676.330651.410 653.902USD -6,539 -
2025-11-07BUY70658.210640.990 642.712USD 44,990 -
2025-11-05SELL-680646.895628.000 629.890USD -428,325 -
2025-10-29SELL-538652.910659.980 659.273USD -354,689 -
2025-10-24SELL-110577.950582.700 582.225USD -64,045 -
2025-10-23SELL-20575.690584.000 583.169USD -11,663 -
2025-10-22BUY30584.740588.710 588.313USD 17,649 -
2025-10-20SELL-230576.770582.650 582.062USD -133,874 -
2025-10-17SELL-120578.050579.040 578.941USD -69,473 -
2025-10-16SELL-50569.170589.080 587.089USD -29,354 -
2025-10-15SELL-125576.420584.870 584.025USD -73,003 -
2025-10-13SELL-187557.730563.770 563.166USD -105,312 -
2025-10-03BUY40600.000618.010 616.209USD 24,648 -
2025-10-02SELL-400600.000605.410 604.869USD -241,948 -
2025-10-01SELL-383599.940615.390 613.845USD -235,103 -
2025-09-30SELL-10562.270574.040 572.863USD -5,729 -
2025-09-29SELL-132560.750564.910 564.494USD -74,513 -
2025-09-26SELL-10563.900564.610 564.539USD -5,645 -
2025-09-25BUY130555.510579.000 576.651USD 74,965 -
2025-09-24SELL-88576.980577.980 577.880USD -50,853 -
2025-09-18BUY20598.710600.000 599.871USD 11,997 -
2025-09-10SELL-10555.830560.000 559.583USD -5,596 -
2025-09-08SELL-10558.440571.200 569.924USD -5,699 -
2025-08-21BUY20598.160605.180 604.478USD 12,090 -
2025-08-19BUY18571.780581.690 580.699USD 10,453 -
2025-07-31SELL-411545.460558.130 556.863USD -228,871 -
2025-07-29BUY11558.150559.610 559.464USD 6,154 -
2025-07-23SELL-30572.390576.700 576.269USD -17,288 -
2025-07-22SELL-60560.930563.000 562.793USD -33,768 -
2025-07-21SELL-20545.530552.980 552.235USD -11,045 -
2025-07-11SELL-30567.740568.460 568.388USD -17,052 -
2025-07-10SELL-120559.760566.370 565.709USD -67,885 -
2025-07-09SELL-40552.580558.380 557.800USD -22,312 -
2025-07-08SELL-130547.750559.460 558.289USD -72,578 -
2025-07-03SELL-170547.360555.000 554.236USD -94,220 -
2025-07-02SELL-31547.740551.500 551.124USD -17,085 -
2025-06-30BUY446525.000526.080 525.972USD 234,584 -
2025-06-27SELL-490521.000531.210 530.189USD -259,793 -
2025-06-25BUY10520.290525.630 525.096USD 5,251 -
2025-06-24SELL-370522.270527.450 526.932USD -194,965 -
2025-06-18SELL-42513.580519.170 518.611USD -21,782 -
2025-06-17SELL-77508.860523.010 521.595USD -40,163 -
2025-06-11SELL-21518.600528.370 527.393USD -11,075 -
2025-06-10SELL-49523.530529.990 529.344USD -25,938 -
2025-06-06SELL-14493.220499.880 499.214USD -6,989 -
2025-06-05SELL-119483.070491.770 490.900USD -58,417 -
2025-06-02SELL-567490.810502.560 501.385USD -284,285 -
2025-05-30SELL-126490.280519.780 516.830USD -65,121 -
2025-05-29SELL-14605.390605.730 605.696USD -8,480 -
2025-05-27SELL-14603.260608.170 607.679USD -8,508 -
2025-05-23SELL-21588.340591.640 591.310USD -12,418 -
2025-05-16SELL-105594.320595.190 595.103USD -62,486 -
2025-05-15SELL-21584.990585.260 585.233USD -12,290 -
2025-05-13SELL-7574.160575.050 574.961USD -4,025 -
2025-05-12SELL-49575.630577.990 577.754USD -28,310 -
2025-05-09SELL-42527.780552.840 550.334USD -23,114 -
2025-05-08SELL-203547.670552.570 552.080USD -112,072 -
2025-05-07SELL-14560.930568.130 567.410USD -7,944 -
2025-05-06BUY8558.520606.870 602.035USD 4,816 -
2025-05-01BUY266590.000593.930 593.537USD 157,881 -
2025-04-30BUY147598.760600.200 600.056USD 88,208 -
2025-04-29SELL-28568.910579.980 578.873USD -16,208 -
2025-04-28SELL-35610.860614.830 614.433USD -21,505 -
2025-04-25BUY14602.640602.790 602.775USD 8,439 -
2025-04-24SELL-7599.760601.280 601.128USD -4,208 -
2025-04-22SELL-938585.490587.100 586.939USD -550,549 -
2025-04-17SELL-427563.160564.210 564.105USD -240,873 -
2025-04-16BUY14549.280561.830 560.575USD 7,848 -
2025-04-15BUY14557.910575.200 573.471USD 8,029 -
2025-04-10SELL-441546.390571.990 569.430USD -251,119 -
2025-04-09BUY35576.720580.730 580.329USD 20,312 -
2025-04-08BUY7556.810586.030 583.108USD 4,082 -
2025-04-07BUY126572.780591.540 589.664USD 74,298 -
2025-04-04BUY77573.450612.990 609.036USD 46,896 -
2025-04-02BUY49625.600628.000 627.760USD 30,760 -
2025-04-01BUY553617.000641.240 638.816USD 353,265 -
2025-03-31BUY21634.230640.720 640.071USD 13,441 -
2025-03-25BUY7634.140662.570 659.727USD 4,618 -
2025-03-21BUY578658.480661.000 660.748USD 381,912 -
2025-03-20BUY14662.620674.830 673.609USD 9,431 -
2025-03-18BUY35664.960678.270 676.939USD 23,693 -
2025-03-17BUY7678.420679.830 679.689USD 4,758 -
2025-03-13SELL-420680.610698.950 697.116USD -292,789 -
2025-03-12BUY84689.500712.460 710.164USD 59,654 -
2025-03-11BUY84718.160747.700 744.746USD 62,559 -
2025-03-07BUY28707.510729.750 727.526USD 20,371 -
2025-03-06BUY98698.440701.000 700.744USD 68,673 -
2025-03-05BUY532687.150692.790 692.226USD 368,264 -
2025-03-04BUY28675.490697.460 695.263USD 19,467 -
2025-03-03BUY35684.870704.640 702.663USD 24,593 -
2025-02-28BUY70698.740708.580 707.596USD 49,532 -
2025-02-27BUY63702.780721.000 719.178USD 45,308 -
2025-02-26SELL-35706.940721.410 719.963USD -25,199 -
2025-02-25SELL-7723.470739.000 737.447USD -5,162 -
2025-02-24BUY7713.250725.000 723.825USD 5,067 -
2025-02-20SELL-91696.020703.140 702.428USD -63,921 -
2025-02-19BUY28685.660688.670 688.369USD 19,274 -
2025-02-18BUY28680.000689.950 688.955USD 19,291 -
2025-02-13BUY798674.270677.690 677.348USD 540,524 -
2025-02-12BUY238663.860670.980 670.268USD 159,524 -
2025-02-11BUY196665.460680.790 679.257USD 133,134 -
2025-02-07BUY21710.000731.420 729.278USD 15,315 -
2025-02-06BUY280722.070734.270 733.050USD 205,254 -
2025-02-05BUY140716.720729.250 727.997USD 101,920 -
2025-02-04BUY105697.050709.980 708.687USD 74,412 -
2025-02-03SELL-609666.850673.650 672.970USD -409,839 -
2025-01-31BUY56672.980688.000 686.498USD 38,444 -
2025-01-30BUY7683.080689.620 688.966USD 4,823 -
2025-01-29BUY119687.270697.570 696.540USD 82,888 -
2025-01-28BUY42686.330690.300 689.903USD 28,976 -
2025-01-27BUY42684.710698.450 697.076USD 29,277 -
2025-01-24BUY42675.790693.840 692.035USD 29,065 -
2025-01-23BUY119694.640696.190 696.035USD 82,828 -
2025-01-22BUY70680.030699.880 697.895USD 48,853 -
2025-01-21BUY413687.800692.930 692.417USD 285,968 -
2025-01-17BUY84681.580707.480 704.890USD 59,211 -
2025-01-15BUY42703.430712.600 711.683USD 29,891 -
2025-01-13BUY119716.900717.370 717.323USD 85,361 -
2025-01-10BUY91696.880724.730 721.945USD 65,697 -
2024-12-31BUY21712.330713.000 712.933USD 14,972 -
2024-12-30BUY28702.590708.970 708.332USD 19,833 -
2024-12-27BUY133712.400718.990 718.331USD 95,538 -
2024-12-23BUY42715.130718.190 717.884USD 30,151 -
2024-12-20BUY4,328701.850717.610 716.034USD 3,098,995 -
2024-12-19BUY48708.250714.050 713.470USD 34,247 -
2024-12-17BUY36740.010744.800 744.321USD 26,796 -
2024-12-16BUY12724.870739.390 737.938USD 8,855 -
2024-12-13BUY20731.300740.170 739.283USD 14,786 -
2024-12-11BUY12773.000781.320 780.488USD 9,366 -
2024-12-10BUY8778.500791.490 790.191USD 6,322 -
2024-12-09BUY8788.000800.990 799.691USD 6,398 -
2024-12-05SELL-24767.900768.020 768.008USD -18,432 -
2024-12-04BUY4754.260756.130 755.943USD 3,024 -
2024-12-02BUY16762.340763.890 763.735USD 12,220 -
2024-11-29BUY72750.220754.510 754.081USD 54,294 -
2024-11-27BUY16754.870762.160 761.431USD 12,183 -
2024-11-26BUY40753.030754.180 754.065USD 30,163 -
2024-11-25BUY496749.510757.860 757.025USD 375,484 -
2024-11-22BUY12738.000751.400 750.060USD 9,001 -
2024-11-21BUY12744.500757.560 756.254USD 9,075 -
2024-11-20BUY52743.350750.690 749.956USD 38,998 -
2024-11-19SELL-52744.600758.600 757.200USD -39,374 -
2024-11-18BUY240762.000762.700 762.630USD 183,031 -
2024-11-12BUY48821.000831.000 830.000USD 39,840 -
2024-11-11BUY12825.680834.420 833.546USD 10,003 -
2024-11-08BUY48828.420830.730 830.499USD 39,864 -
2024-11-07BUY80824.480832.530 831.725USD 66,538 -
2024-11-06BUY36816.650844.510 841.724USD 30,302 -
2024-11-05BUY8829.430836.630 835.910USD 6,687 -
2024-11-04BUY40828.840852.010 849.693USD 33,988 -
2024-11-01BUY20843.600862.000 860.160USD 17,203 -
2024-10-31SELL-184838.200883.150 878.655USD -161,673 -
2024-10-30BUY12922.790935.860 934.553USD 11,215 -
2024-10-29BUY76927.330932.380 931.875USD 70,823 -
2024-10-25BUY16933.020943.830 942.749USD 15,084 -
2024-10-24BUY12928.900952.020 949.708USD 11,396 -
2024-10-22BUY24962.340972.750 971.709USD 23,321 -
2024-10-21BUY20968.500991.240 988.966USD 19,779 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy